Dark Blue Therapeutics News and Activities

Dark Blue Therapeutics is owned by Amgen.

Amgen is one of the...

• Forbes Global 2000 (#202);
• Fortune 500 (#151);
• Global Fortune 500 (#482);
• Nasdaq 100;
• Russell 3000;
• S&P 500;
• TOB Iconic 10,000.

Amgen is a company listed under the stock ticker AMGN (US).

Amgen has a direct presence in 22 countries.

Amgen has 26 subsidiaries including Amgen APAC, Amgen Argentina and Amgen Australia.

They are in:

• Pharmaceuticals78%
• Biotechnology22%

Acquisition, funding and merger involving Amgen.

• Amgen has acquired Dark Blue Therapeutics (posted on January 7 2026).

View the org chart displaying its 13 main executives

Most searched biographies at Dark Blue Therapeutics

• Alastair Mackinnon, Chief Executive Officer
• Sally Dewhurst, Director
• Thomas Hanke, Director

Popular executive movements at Dark Blue Therapeutics

• Iain Simpson, Head of Chemistry, has left the company  (posted on May 20 2026).

Popular executive movements at Amgen

• Thomas Dittrich has joined the company as Chief Financial Officer  (posted on May 20 2026).
• Peter Griffith, Executive Vice President and Chief Financial Officer, will leave the company on Sep. 1, 2026  (posted on May 20 2026).
• David Reese, Executive Vice President and Chief Technology Officer, will leave the company on Jun. 30, 2026  (posted on April 23 2026).

Click here to view some more movements at Amgen

Create your alert
to follow the executive moves at Dark Blue Therapeutics.

Amgen has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Dark Blue Therapeutics

Social media about Dark Blue Therapeutics

• Dark Blue Therapeutics on Wikipedia, Google News & Yahoo Finance
• Dark Blue Therapeutics on LinkedIn, X (Twitter) & YouTube